Browse the full record of transactions filed by Hahn Mark W, Chief Financial Officer. Director active across 1 companies, notably Verona Pharma plc. In total, 10 reports have been recorded. Total volume traded: €6k. The latest transaction was disclosed on 3 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Mark W. Hahn is the Chief Financial Officer at Verona Pharma plc. He oversees the financial management of the company, including financial planning and reporting. With a strong background in the pharmaceutical sector, he plays a key role in formulating financial strategies aimed at supporting Verona Pharma's growth and innovation.